Annex
United Kingdom
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘triclabendazole’ is replaced by the following:
Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Triclabendazole Sum of the extractable residues that may be oxidised to ketotriclabendazole All ruminants 225 μg/kg
100 μg/kg
250 μg/kg
150 μg/kg
10 μg/kg
Muscle
Fat
Liver
Kidney
Milk
NO ENTRY Antiparasitic agents/Agents against endoparasites’